arnica
Botanicalexperimental
Arnica is a genus of perennial, herbaceous plants in the sunflower family (Asteraceae). The genus name Arnica may be derived from the Greek arni, "lamb", in reference to the plants' soft, hairy leaves. Arnica is also known by the names mountain tobacco and, confusingly, leopard's bane and wolfsbane—two names that it shares with the entirely unrelated genus Aconitum. — Wikipedia
Clinical trial activity
19 trials · 27 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
4
Phase 4
4
Earliest trial started Dec 31, 2003 (NCT00222365)
Timeline
Indications
Approved for
Studied for
- Acute Pain · Phase 2/Phase 3
- Aortic Valve Disease · Phase 4
- Arnica · Phase 1
- Cellulite · Phase 4
- Exercise · Phase 1
- Hemorrhage · Phase 1
- Hemorrhoids · Phase 4
- Leishmaniasis, Cutaneous · Phase 3
- Muscles · Phase 1
- Myalgia · Phase 2/Phase 3
- Pain · Phase 3
- Panniculitis · Phase 4
- Temporomandibular Joint Disorders · Phase 2/Phase 3
- Tooth Abnormalities · Phase 4
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaArnica ↗
- NCATSOZ0E5Y15PZ ↗
- WikipediaArnica montana ↗
Also known as
- arnica
- arnica
- arnica montana
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06822478 | Phase 3 | Oct 31, 2025 | INNOVATION CORPORATION FOR THE DEVELOPMENT OF PRODUCTS FOR TROPICAL DISEASES (CIDEPRO), Universidad de Antioquia |
| NCT06193720 | N/A | Feb 3, 2022 | Saint-Joseph University |
| NCT05094908 | Phase 1/Phase 2 (Phase 2) | Jan 31, 2022 | INNOVATION CORPORATION FOR THE DEVELOPMENT OF PRODUCTS FOR TROPICAL DISEASES (CIDEPRO), Universidad de Antioquia |
| NCT04533269 | N/A | Jul 31, 2021 | Cearna, Inc. |
| NCT05283434 | Phase 2/Phase 3 (Phase 3) | Jul 15, 2021 | University of Minnesota |
| NCT04677712 | Phase 4 | Dec 28, 2020 | DeNova Research, Endo Pharmaceuticals, Investigate MD, LLC, University of California, San Diego |
| NCT06231212 | Phase 2/Phase 3 (Phase 3) | Aug 5, 2020 | Chulalongkorn University |
| NCT04683263 | N/A | Jun 1, 2019 | Clinica Quirón Salud, Córdoba, Hospital QuiroSalud Barcelona, J. Uriach and Company |
| NCT04534426 | Phase 4 | Dec 1, 2018 | Abant Izzet Baysal University |
| NCT03586232 | N/A | Nov 30, 2018 | Boston University |
| NCT03569930 | Phase 4 | May 1, 2018 | University of Roma La Sapienza |
| NCT03520595 | N/A | Dec 1, 2016 | Tatyasaheb Kore Dental College |
| NCT01598909 | N/A | Jan 1, 2013 | Isala Clinics, Zwolle, The Netherlands, Wynand BWH Melenhorst, MD |
| NCT01164644 | N/A | Jun 1, 2010 | University of Wisconsin |
| NCT00504010 | Phase 1 | Aug 1, 2007 | Memorial Hermann Health System, University of Texas at Houston |
| NCT00405626 | Phase 1 | Apr 30, 2007 | Hebrew University |
| NCT00363038 | N/A | Jul 1, 2006 | Northwestern University |
| NCT00774293 | Phase 4 | Sep 30, 2004 | BOIRON, University of Lyon |
| NCT00222365 | Phase 3 | Dec 31, 2003 | University of Grenoble |
Showing 19 of 19 trials
Page 1 / 1
Organizations
Research & Development (27)
27 organizations
Page 1 / 2